SAN DIEGO--(BUSINESS WIRE)--PrecisionMed Inc. today announced enrollment of the first subject into THE SAMPLE REGISTRY (Serial Alzheimer’s Disease and MCI Prospective Longitudinal Evaluation). The SAMPLE Registry is a biological sample bank of DNA and serial RNA, CSF, serum and plasma associated with serial cognition testing utilizing PrecisionMed’s clinical sample and data procurement and storage capabilities.
